---
title: Antimicrobial Resistance Diagnostics Market, Global, 2024–2030
description: The Shift to Whole-genome Sequencing and Multiplex Point-of-care Testing is Driving Transformational Growth Due to Improved Speed, Accuracy, and High Throughput
image: https://go.frost.com/hubfs/Images/2025/HLS/GO/R01_D01_Mktg_Banner_HLS_AMR_GO_800x400_030325_MA_KL.jpg
---

![Antimicrobial Resistance Diagnostics Market](https://go.frost.com/hs-fs/hubfs/Images/2025/HLS/GO/R01_D01_Mktg_Banners_HLS_AMR_GO_2500x500_030325_MA_KL.jpg?width=2000&height=400&name=R01_D01_Mktg_Banners_HLS_AMR_GO_2500x500_030325_MA_KL.jpg "Antimicrobial Resistance Diagnostics Market")

The growing threat of antimicrobial resistance (AMR) is driving rapid advancements in diagnostic technologies. Next-generation solutions such as whole-genome sequencing and multiplex point-of-care testing (POCT) are addressing critical challenges in pathogen identification, treatment selection, and infection control.

Industry Shifts & Analysis

- The AMR diagnostics landscape is evolving with molecular platforms gaining traction due to their high accuracy and rapid turnaround times.
- The sector is led by bioMérieux, Danaher, and Thermo Fisher Scientific, with the top three competitors commanding 84% revenue share.
- Strategic mergers and acquisitions, such as bioMérieux’s acquisition of Specific Diagnostics and Roche’s acquisition of GenMark, are shaping the competitive landscape.

Strategic Imperatives

- **Technological Disruption: **The integration of AI-driven whole-genome sequencing (WGS), next-generation sequencing (NGS), and microfluidics is revolutionizing AMR testing.
- **Market Expansion: **The demand for multiplex POCT in decentralized settings (local clinics, pharmacies, and rural healthcare centers) is unlocking new growth avenues.
- **Collaborative Business Models:** Public-private partnerships are essential to expanding diagnostic access and improving affordability in low-resource settings.

[ Instant Access ](https://store.frost.com/antimicrobial-resistance-diagnostics-market-global-2024-2030.html?utm_campaign=GO_HLS_PFR3_AntimicrobialResistanceDiagnosticsMarketGlobal)

Explore the complete industry outlook and competitive intelligence in our latest analysis.

### Download Sample

### Sign up for a complimentary Growth Pipeline Dialog™

A Growth Pipeline Dialog is a structured discussion with our growth experts providing unparalleled technology intelligence and proven implementation best practices. This discussion will spark innovative thinking and help generate a pipeline of growth opportunities you can leverage to maximize your company’s future growth potential.

Upon completing the dialog session, you will receive a $1,000 honorarium* as a token of our appreciation, which can be used towards the purchase of our products and services on [store.frost.com](https:/store.frost.com?utm_source=hslinks).

[ Talk to our experts today! ](https://insights.frost.com/gpdialog?hsCtaTracking=2540db65-be35-44dd-abb4-f667210b0fde%7C973ed019-8950-4e26-8c86-4b58d2df9b85&hsLang=en)

*$1,000 honorarium is subject to eligibility

![drive-growth-image-scaled-2](https://go.frost.com/hubfs/Imported%20sitepage%20images/drive-growth-image-scaled-2.jpg "drive-growth-image-scaled-2")

**